Ads
    Related conference
  1. FORMULAITON AND PHARMACOKINETIC EVALUATION OF NAPROXEN SODIUM MODIFIED RELEASE TABLET
  2. FORMULATION AND EVALUATION OF NAPROXEN SUSTAINED RELEASE MATRIX TABLET
  3. FORMULATION AND EVALUATION OF MODIFIED DISINTEGRATING SUSTAINED RELEASE TABLETS OF DICLOFENAC SODIUM
  4. DEVELOPMENT OF STABILITY INDICATING RP-HPLC-PDA METHOD FOR THE SIMULTANEOUS ANALYSIS OF NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE IN BULK AND TABLET DOSAGE FORMS
  5. RAPID SIMULTANEOUS ESTIMATION OF SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM IN TABLET DOSAGE FORMS USING A VALIDATED STABILITY- INDICATING MONOLITHIC LC METHOD
  6. Formulation and Evaluation of Gliclazide Immediate Release and Metformin Sustain Release Bilayer Tablet
  7. FORMULATION AND EVALUATION OF SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM GASTRORETENTIVE (FLOATING) BILAYERED TABLETS
  8. Formulation and Development of Modified Release Biphasic Compressed Tablet of Propranolol Hydrochloride
  9. PHARMACOKINETIC EVALUATION OF PLGA & PLA BASED LONG ACTING RELEASE (LAR) MICROSPHERE FORMULATIONS OF CETRORELIX IN RATS
  10. FORMULATION AND EVALUATION OF METFORMIN IMMIDIATE RELEASE TABLET